AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Thorn GroupLtd

1.165

0.000

Volume:- -

Turnover:- -

Market Cap:40.50M

PE:3.99

High:1.165

Open:1.165

Low:1.165

Close:1.165

52wk High:1.165

52wk Low:1.165

Shares:34.76M

Float Shares:10.56M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.292

EPS(LYR):0.073

ROE:-5.00%

ROA:2.77%

PB:0.95

PE(LYR):15.85

Loading ...

Overview Company News Filings

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

PharmaCare Streamlines ANZ Operations and Strengthens Compliance with Manhattan Associates

Major development in weight loss management

The West Australian

LTR Pharma Says Over 1,000 Spontan Prescriptions Issued Under TGA Special Access Scheme

MT Newswires Live

Bubble Burst? MSTR: A Liquidity Crisis More Brutal Than Bitcoin’s Crash

U.S. Treasury General Account (TGA) sees significant downward trend for the first time, market liquidity expected to improve

Real Vision Founder: U.S. Government Restart to Trigger a Series of Liquidity Tailwinds

Bitunix Analyst: U.S. Government Shutdown Breakthrough Signals Potential Liquidity Return to Crypto Markets

NeuroScientific widens chronic bowel disease stem cell therapy program

The West Australian

'The MSTR Model Is Dead': Relief Rally in Crypto-treasury Stocks as U.S. Shutdown Ends

Why Assets Are Selling Off Across the Board?

HTX DeepThink: Federal Reserve Ends Balance Sheet Reduction Signaling Liquidity, Bitcoin Seeks Breakout Momentum Amid Consolidation

Why Chris Judd thinks investors are looking for bubbles in the wrong place

Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership

ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter

TGA backs NeuroScientific stem cell assault on Crohn’s disease

The West Australian

Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance

Telix Announces Record-Breaking Presence at EANM 2025

More sunscreens pulled from shelves amid SPF concernsA further 18 sunscreens have been recalled or paused from sale in Australia.2 min read

IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TGA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TGA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TGA.AU\",,,,,undefined,":{"symbol":"TGA.AU","market":"AU","secType":"STK","nameCN":"Thorn GroupLtd","latestPrice":1.165,"timestamp":1772168400000,"preClose":1.165,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"Thorn GroupLtd","floatShares":10555948,"shares":34764019,"eps":0.291847,"marketStatus":"Market Closed","change":0,"latestTime":"02-27 16:00:00 AEDT","open":1.165,"high":1.165,"low":1.165,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.291847,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772406000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.165,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TGA.AU\",,,,,undefined,":{"symbol":"TGA.AU","floatShares":10555948,"roa":"2.77%","roe":"-5.00%","lyrEps":0.073491,"shares":34764019,"dividePrice":0,"high":1.165,"amplitude":0,"preClose":1.165,"low":1.165,"week52Low":1.165,"pbRate":"0.95","psRate":"2.87","week52High":1.165,"institutionHeld":0,"latestPrice":1.165,"eps":0.291847,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.291847,"open":1.165,"prevYearClose":1.165,"prevWeekClose":1.165,"prevMonthClose":1.165,"prevQuarterClose":1.165,"fiveDayClose":1.165,"twentyDayClose":1.165,"sixtyDayClose":1.165},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TGA.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-12-13","symbol":"TGA.AU","reason":null,"defaultRemindTime":1702422000000,"announcedDate":"2023-12-11","type":"delisting","dateTimestamp":1702386000000},{"date":"2023-11-30","symbol":"TGA.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1701298800000,"name":null,"time":"","dateTimestamp":1701262800000,"actualEps":null},{"date":"2023-09-05","symbol":"TGA.AU","amount":0.45,"announcedDate":"2023-08-01","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Thorn GroupLtd","recordDate":"2023-09-22","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-22"},{"date":"2023-05-31","symbol":"TGA.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1685491200000,"name":null,"time":"","dateTimestamp":1685455200000,"actualEps":null},{"date":"2022-11-30","symbol":"TGA.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1669762800000,"name":null,"time":"","dateTimestamp":1669726800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TGA.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-10-16","recordDate":"2020-10-19","paymentDate":"2020-11-03","value":0.075,"currency":"AUD"},{"executeDate":"2021-07-02","recordDate":"2021-07-05","paymentDate":"2021-07-21","value":0.01,"currency":"AUD"},{"executeDate":"2022-01-24","recordDate":"2022-01-25","paymentDate":"2022-02-09","value":0.07,"currency":"AUD"},{"executeDate":"2022-07-06","recordDate":"2022-07-07","paymentDate":"2022-07-25","value":0.01,"currency":"AUD"},{"executeDate":"2022-08-24","recordDate":"2022-08-25","paymentDate":"2022-09-08","value":0.03,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TGA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614071800","title":"Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071800","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071800?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:01","pubTimestamp":1772139660,"startTime":"0","endTime":"0","summary":"OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration  class IIb approval in Australia for the Virtual Nodule Clinic  platform to support early lung cancer diagnosis. This important regulatory milestone was achieved after a rigorous review of technical documentation and validation studies, recognizing its safety and performance for clinical use. VNC helps identify, triage, and manage patients with pulmonary nodules, and includes a clinically validated AI decision support tool, lung cancer prediction  AI, already used in the US and EU/UK for nodule risk stratification.This TGA clearance poises Optellum to help thousands of patients in Australia by supporting earlier and more consistent identification of incidental lung nodules. By helping care teams prioritize higher-risk findings and streamline follow-up more efficiently, VNC aims to reduce","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2633244/Optellum_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2633244/Optellum_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/optellum-secures-tga-approval-to-expand-ai-enabled-lung-nodule-solution-to-australia-302698996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4023","BK4588","BK4585","AIYY","XKO.AU","XJO.AU","BK4587","BK4528","BK7001","BK4543","TGA","XAO.AU","BK4213","TGA.AU"],"gpt_icon":1},{"id":"2610660413","title":"PharmaCare Streamlines ANZ Operations and Strengthens Compliance with Manhattan Associates","url":"https://stock-news.laohu8.com/highlight/detail?id=2610660413","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610660413?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:34","pubTimestamp":1770683640,"startTime":"0","endTime":"0","summary":"SYDNEY, Feb. 10, 2026 /PRNewswire/ --Manhattan Associates , the global leader insupply chain commercewith unmatched AI capabilities, today announced that PharmaCare, one of Australia's largest health and wellness companies, has transformed its ANZ distribution network with Manhattan SCALE. The implementation has streamlined receiving workflows by 25%, delivering a 20% increase in daily pick rates, along with automating key TGA-licensed compliance processes.PharmaCare manages more than 25 iconic brands, including Nature's Way and Bioglan, and distributes over 1,000 products across pharmacy, grocery and export channels. As the business has expanded from 2009 to six times its size now in 2026, its legacy warehouse environment had become increasingly fragmented, with multiple systems managing radio frequency  networks, voice picking, conveyor control and SSCC labelling.\"We were dealing with multiple systems that didn't talk to each other, manual data entry for hundreds of pallets a day, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pharmacare-streamlines-anz-operations-and-strengthens-compliance-with-manhattan-associates-302683146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MANH","BK7001","BK4585","BK4211","LU0390134368.USD","LU1883839398.USD","IE00B64QTZ34.USD","RF","TGA","IE00BLDYK493.USD","LU1880398554.USD","TGA.AU","BK4213","BK4023","LU1880398471.USD"],"gpt_icon":0},{"id":"2593646544","title":"Major development in weight loss management","url":"https://stock-news.laohu8.com/highlight/detail?id=2593646544","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593646544?lang=en_us&edition=fundamental","pubTime":"2025-12-23 01:30","pubTimestamp":1766424606,"startTime":"0","endTime":"0","summary":"A semaglutide pill, an alternative to injections like Wegovy and Ozempic, has been approved for use by a major drug administration, welcoming a new era of weight loss management. ","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-21094068/fe4f134e58b6cd5a3348b75d08a7c7a4db1f7a58.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21094068/fe4f134e58b6cd5a3348b75d08a7c7a4db1f7a58.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/health/wegovy-pill-weight-loss-oral-medication-approved-by-us-food-and-drug-administration-c-21094068","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/health/wegovy-pill-weight-loss-oral-medication-approved-by-us-food-and-drug-administration-c-21094068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["TGA","BK4213","TGA.AU","BK7001"],"gpt_icon":0},{"id":"2592957089","title":"LTR Pharma Says Over 1,000 Spontan Prescriptions Issued Under TGA Special Access Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2592957089","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592957089?lang=en_us&edition=fundamental","pubTime":"2025-12-17 10:58","pubTimestamp":1765940328,"startTime":"0","endTime":"0","summary":"LTR Pharma  said over 1,000 prescriptions of Spontan had been issued in Australia under the Therapeutic Goods Administration  Special Access Scheme, according to a Wednesday Australian bourse filing.Under the scheme, clinicians can request access to Spontan where approved treatments are unsuitable, ineffective, or unavailable.De-identified data collection from the prescriptions under the scheme is ongoing.Its shares rose 2% in recent trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TGA.AU","BK7001","BK7096","BK4213","LTP.AU","TGA"],"gpt_icon":0},{"id":"2589697328","title":"Bubble Burst? MSTR: A Liquidity Crisis More Brutal Than Bitcoin’s Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2589697328","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589697328?lang=en_us&edition=fundamental","pubTime":"2025-12-05 14:42","pubTimestamp":1764916920,"startTime":"0","endTime":"0","summary":"MSTR stock crash analysis: Premium bubble burst and convertible debt mechanics drove losses beyond BTC's drop. Examines MSTR's debt defense and concludes it's a valuation reset, not a crisis.","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20241111/dbf2ce80b85c46fd8717286df0c150a5mstr.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20241111/dbf2ce80b85c46fd8717286df0c150a5mstr.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/251368708-microstrategy-mstr-bitcoin-liquidity-crisis-premium-death-spiral-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","83042","MSTR","BK4600","09008","BK4516","03042","BTC.USD.CC","BTC.USD.HKCC","BK1611","STRK","09042","BK7001","BK4594","BK4585","BK4601","09439","03439","TGA.AU","BK4023","BK4595","TGA","03008","BK4588","BK4596"],"gpt_icon":1},{"id":"2584956639","title":"U.S. Treasury General Account (TGA) sees significant downward trend for the first time, market liquidity expected to improve","url":"https://stock-news.laohu8.com/highlight/detail?id=2584956639","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584956639?lang=en_us&edition=fundamental","pubTime":"2025-11-19 10:01","pubTimestamp":1763517660,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 19th, the latest data shows a significant decline in the U.S. Treasury General Account  cash balance for the first time: Treasury cash decreased from $959 billion to $925 billion, a $340 billion drop.J.P. Morgan's trading desk believes that repo market pressure was a key driver of this month's stock market reversal. Due to a combination of government shutdown, TGA growth, and Quantitative Tightening , the U.S. Treasury had previously absorbed a large amount of capital, leading to a deterioration in cash availability within the financial system.Now, the U.S. Treasury has started releasing funds, and market liquidity is expected to improve. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/321017","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/321017","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["TGA.AU","TLT","TGA","TLTW","US12M.BOND","US5Y.BOND","US3Y.BOND","BK4213","US7Y.BOND","BK7001","US2Y.BOND","TMF","US6M.BOND","US30Y.BOND","US10Y.BOND"],"gpt_icon":1},{"id":"2583527707","title":"Real Vision Founder: U.S. Government Restart to Trigger a Series of Liquidity Tailwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2583527707","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583527707?lang=en_us&edition=fundamental","pubTime":"2025-11-14 15:08","pubTimestamp":1763104080,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 14th, Real Vision co-founder and CEO Raoul Pal published an article discussing the post-reopening macroeconomic outlook for the United States government, stating: It is expected that within a few days, the US Treasury General Account  spending will begin to significantly increase market liquidity and continue for several months. Quantitative tightening  will end in December, and the balance sheet will begin to gradually expand. This will be followed by the US dollar weakening once again.Raoul Pal stated that the policymakers' next critical step is to avoid year-end funding strains. It is expected that several \"temporary\" measures will be implemented to increase liquidity, with the most likely being term funding and the Standing Repo Facility  operations. Debt must be extended, and the government hopes to avoid an overheated economy before the midterm elections. In short, a liquidity tsunami is on the way.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/320505","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/320505","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["SRF.AU","TGA","BK7001","BK4213","TGA.AU"],"gpt_icon":0},{"id":"2582331887","title":"Bitunix Analyst: U.S. Government Shutdown Breakthrough Signals Potential Liquidity Return to Crypto Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2582331887","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582331887?lang=en_us&edition=fundamental","pubTime":"2025-11-11 12:39","pubTimestamp":1762835940,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 11th, the U.S. Senate passed a temporary funding bill extending government operations until January 30, 2026, marking a crucial step toward ending the longest federal shutdown in history. Although the agreement still awaits House approval, expectations of renewed liquidity have immediately lifted market sentiment. The move could release billions of dollars previously trapped in the Treasury General Account , allowing idle funds to re-enter the financial system and energize risk assets.For the crypto market, this potential breakthrough carries significant implications: The liquidity inflow could strengthen capital support for major regulated assets like BTC and ETH. If regulatory agencies such as the SEC resume full operations, the approval pace of crypto ETFs and related instruments may accelerate — providing new entry opportunities for institutional capital.However, investors should remain cautious: any blockage in the House or sudden acceleration in regulato","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/319977","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/319977","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4213","TGA.AU","TGA","BK7001"],"gpt_icon":0},{"id":"2582335604","title":"NeuroScientific widens chronic bowel disease stem cell therapy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2582335604","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582335604?lang=en_us&edition=fundamental","pubTime":"2025-11-11 03:09","pubTimestamp":1762801783,"startTime":"0","endTime":"0","summary":"NeuroScientific Biopharmaceuticals has dosed a fourth Crohn’s disease patient with its StemSmart stem-cell therapy, in a step towards phase two trials of a novel treatment for the debilitating bowel condition.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20642965/8cf0d5e89af17551de3b51f676a391c7f46f6af5.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20642965/8cf0d5e89af17551de3b51f676a391c7f46f6af5.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/neuroscientific-widens-chronic-bowel-disease-stem-cell-therapy-program-c-20642965","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/neuroscientific-widens-chronic-bowel-disease-stem-cell-therapy-program-c-20642965","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4213","MSC","TGA.AU","BK4575","TGA","BK7001","BK4150"],"gpt_icon":0},{"id":"2582879305","title":"'The MSTR Model Is Dead': Relief Rally in Crypto-treasury Stocks as U.S. Shutdown Ends","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879305","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879305?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:53","pubTimestamp":1762779221,"startTime":"0","endTime":"0","summary":"TradingKey - Crypto treasury companies, many of which emulate the \"MicroStrategy model,\" are facing significant challenges. However, with the end of the US government shutdown now in sight, crypto investors are shifting their focus to improved liquidity as a potential catalyst for a reversal of ","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20240105/f99e159fb40dee42c7754b6b6d7a7bc6.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20240105/f99e159fb40dee42c7754b6b6d7a7bc6.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/251288920-dat-digital-asset-treasury-stock-strategy-mstr-bitcoin-risk-shutdown-end-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["METHmain","ETH.USD.HKCC","BTC.USD.CC","SOL.USD.HKCC","BK7001","TON.USD.HKCC","US2Y.BOND","TMF","03009","US30Y.BOND","US10Y.BOND","US3Y.BOND","TLTW","83042","09009","09439","US7Y.BOND","BTC.USD.HKCC","03008","ETHV","US12M.BOND","TGA","LDO.USD.HKCC","MSTR","APT.USD.CC","03042","09042","09046","CETH","DAT","STRK","TON.USD.CC","09179","QETH","US6M.BOND","EZET","APT.USD.HKCC","03046","03179","03439","MBTmain","FETH","TGA.AU","US5Y.BOND","ETH.USD.CC"],"gpt_icon":1},{"id":"2581629727","title":"Why Assets Are Selling Off Across the Board?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581629727","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581629727?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:32","pubTimestamp":1762345942,"startTime":"0","endTime":"0","summary":"TradingKey - Despite a broadly better-than-expected earnings season for U.S. equities, risk sentiment has shifted noticeably. On Tuesday, the market saw a sharp pullback—led by some of the very tech names that had been powering year-to-date gains.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20240102/f64a8c704eef624f478bbf63dc4b40c6.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20240102/f64a8c704eef624f478bbf63dc4b40c6.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/economic/more/251272833-asset-selling-off-stock-foam-qt-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMF","ZION","TGA.AU","LU0106831901.USD","BK4585","BK4504","US10Y.BOND","BK7001","LU1668664300.SGD","US30Y.BOND","BK4213","TGA","US6M.BOND","US2Y.BOND","VTC","BK4561","LU1791807156.HKD","US3Y.BOND","US5Y.BOND","BK4550","US7Y.BOND","BK4589","BK4211","TLTW","US12M.BOND","WAL","LQD","BK4588"],"gpt_icon":1},{"id":"2580788063","title":"HTX DeepThink: Federal Reserve Ends Balance Sheet Reduction Signaling Liquidity, Bitcoin Seeks Breakout Momentum Amid Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2580788063","media":"Blockbeats","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580788063?lang=en_us&edition=fundamental","pubTime":"2025-11-04 16:30","pubTimestamp":1762245000,"startTime":"0","endTime":"0","summary":"BlockBeats News, November 4th, HTX DeepThink columnist and HTX Research researcher Chloe (@ChloeTalk1) analyzed and pointed out that the Federal Reserve announced that it will stop its balance sheet r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/319035","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/319035","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["US5Y.BOND","BK4213","TMF","US6M.BOND","BK1611","83042","US10Y.BOND","BK4594","TGA","TLTW","BK4588","BK7001","MBTmain","BK4601","US30Y.BOND","US3Y.BOND","TGA.AU","09439","09008","US2Y.BOND","US12M.BOND","BTC.USD.CC","BTC.USD.HKCC","09042","03042","US7Y.BOND","BK4585"],"gpt_icon":1},{"id":"2577353820","title":"Why Chris Judd thinks investors are looking for bubbles in the wrong place","url":"https://stock-news.laohu8.com/highlight/detail?id=2577353820","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577353820?lang=en_us&edition=fundamental","pubTime":"2025-10-24 04:00","pubTimestamp":1761249643,"startTime":"0","endTime":"0","summary":"Plenty of investors talk macro. The Cerruty Macro Fund makes it useful. Founder and portfolio manager, Chris Judd, uses big-picture signals to narrow the field to a handful of durable tailwinds, then applies uncompromising bottom-up work to pick stock winners.The result is a process that is deliberate rather than doctrinaire: macro to focus the hunt; management quality, unit economics and alignment to make the call; and active position sizing that reflects the liquidity regime. It’s the combination - not any single lever – that has driven Cerruty’s 27.6% annualised return since inception .“Macro is a way to explain what’s going on in the world, which is really appealing to me”, says Judd.From there, the discipline shows up in the details. Cerruty maps investable themes  and ignores the daily noise that crowds most inboxes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/why-chris-judd-thinks-investors-are-looking-for-bubbles-in-the-wrong-place","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/why-chris-judd-thinks-investors-are-looking-for-bubbles-in-the-wrong-place","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["VYS.AU","BK7084","TGA.AU","BK7095","BK7001","TGA","BK4213","IKE.AU","MLG.AU"],"gpt_icon":0},{"id":"2576600257","title":"Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2576600257","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576600257?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:56","pubTimestamp":1760918195,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals and private Indian company Cadila Pharmaceuticals have entered into a licence and supply agreement covering two new generic medicines for the Australian and New Zealand markets.The agreement will formalise an operational framework for the partnership and will see Algorae commence planning for Therapeutic Goods Administration  registration to enable commercialisation of the products, which will target key therapeutic areas including cardiovascular and metabolic disorders.Cadila operates manufacturing facilities in the US, UK, European Union, and Australia, and its products are distributed in over 100 countries, supported by a workforce of more than 9,000 professionals and a research and development division comprising more than 350 scientists.Algorae chief commercial officer Vishal Shah said the agreement would expand Algorae’s commercial footprint into new regions.“This deal represents an important step in executing our commercial strategy and expanding our prod","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XKO.AU","XJO.AU","BK7001","EBO.AU","BK7103","TGA","TGA.AU","1AI.AU","BK4213","XAO.AU","BK7067"],"gpt_icon":0},{"id":"2573093339","title":"ECS Botanics Achieves Positive Cash Flow Breakthrough in September Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2573093339","media":"Small Caps","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573093339?lang=en_us&edition=fundamental","pubTime":"2025-10-07 09:14","pubTimestamp":1759799658,"startTime":"0","endTime":"0","summary":"ECS Botanics Holdings has delivered a positive net operating cash flow of $140,000 for the three months to end September, representing an improvement of $1.6 million on the June quarter and $900,000 on the same time last year.The company’s direct-to-consumer  strategy generated strong results to complement its established business-to-business  and export channels.Higher sales, disciplined cost optimisation, and reduced labour costs associated with capital works also underpinned the rebound.B2C revenue increased 21% on the June quarter to $3.2m, with growth recorded across all product lines, enabling the division to represent 56% of total revenue.This B2C growth plus an expansion in business-to-business  sales resulted in total unaudited revenue for the period of $5.7m .The strategy has supported further growth in the B2B offering and strengthened relationships with prescribers who seek out trusted Australian products manufactured in line with frameworks offered by the Therapeutic Goods","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/ECS-Botanics-ASX-Positive-Cash-Flow-Breakthrough-September-Quarter.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/ECS-Botanics-ASX-Positive-Cash-Flow-Breakthrough-September-Quarter.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/ecs-botanics-achieves-positive-cash-flow-breakthrough-september-quarter/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/ecs-botanics-achieves-positive-cash-flow-breakthrough-september-quarter/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["TGA.AU","BK4018","TGA","BK7502","XKO.AU","XAO.AU","ODC","BK4213","ECS.AU","XJO.AU","BK7001","BK7096"],"gpt_icon":0},{"id":"2573932944","title":"TGA backs NeuroScientific stem cell assault on Crohn’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2573932944","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573932944?lang=en_us&edition=fundamental","pubTime":"2025-10-07 06:14","pubTimestamp":1759788888,"startTime":"0","endTime":"0","summary":"NeuroScientific has received approval from Australia’s drug regulator to treat its first patients with Crohn’s disease using its “StemSmart” stem cell therapy, in a major step towards a phase two trial in 2026.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20268658/89e53c2b169dbdca6e2f72e073caeae7dd046728.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20268658/89e53c2b169dbdca6e2f72e073caeae7dd046728.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/tga-backs-neuroscientific-stem-cell-assault-on-crohns-disease-c-20268658","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/tga-backs-neuroscientific-stem-cell-assault-on-crohns-disease-c-20268658","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4213","BK7001","TGA","TGA.AU"],"gpt_icon":0},{"id":"2572934035","title":"Echo IQ Reports Strong US Performance of EchoSolv AS Platform Ahead of Regulatory Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2572934035","media":"Small Caps","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572934035?lang=en_us&edition=fundamental","pubTime":"2025-10-02 12:13","pubTimestamp":1759378391,"startTime":"0","endTime":"0","summary":"Perth-based medical technology companyEcho IQ has reported strong operational momentum from its EchoSolv AS platform in the US market, with a 153% increase in echocardiograms over the three months to September.The performance has come about through extensive engagement with US hospital groups, which have integrated the technology into their operations, resulting in the platform’s analysis of more than 90,000 echocardiograms globally.The company said it was a major milestone that provided it with considerable confidence in the continued use of the technology.Echo IQ is now is advancing a dedicated conversion strategy, with final demonstrations and beta testing underway at a number of large hospital groups and clinics throughout the US, and anticipates additional integrations in coming months.Echo IQ chief executive officer Dustin Haines said the company continues to build strong momentum across all key workstreams, and expects the increase in platform use to start generating revenue bef","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EchoIQ-ASX-EIQ-Strong-US-Performance-EchoSolv-AS-Platform-Regulatory-Clearance.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EchoIQ-ASX-EIQ-Strong-US-Performance-EchoSolv-AS-Platform-Regulatory-Clearance.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/echo-iq-strong-performance-echosolv-as-platform-us-market-regulatory-clearance/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/echo-iq-strong-performance-echosolv-as-platform-us-market-regulatory-clearance/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK4531","BK4213","TGA.AU","BK7016","BK4526","BK4505","BK4552","BK4108","EIQ.AU","TGA","IQ","BK7001"],"gpt_icon":0},{"id":"2572558372","title":"Telix Announces Record-Breaking Presence at EANM 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572558372","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572558372?lang=en_us&edition=fundamental","pubTime":"2025-10-01 13:57","pubTimestamp":1759298220,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Sept. 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited  today announces its record-breaking conference presence with 28 company-related abstract presentations at the 38th Annual Congress of the European Association of Nuclear Medicine  to be held in Barcelona from 4 – 8 October 2025.Dr. David N. Cade, Telix Group Chief Medical Officer, said, \"We are pleased to showcase our late-stage and next generation development programs and innovations in MedTech at EANM – the largest gathering of nuclear medicine professionals worldwide. Telix presentation highlights include the Phase 3 ProstACT Global trial of TLX591 in mCRPC[1], the IPAX-Linz and IPAX-2 therapeutic trials of TLX101 in glioma, and real-world experience with TLX250-CDx in ccRCC[2]. Telix will host a sponsored symposium on CAIX[3] and FAP[4] targeting theranostics, and abstracts will also be presented from Telix's pan-tumor programs and its Rhine Pharma subsidiary, whose mission is to expand global acces","market":"us","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-announces-record-breaking-presence-at-eanm-2025-302572028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","BK4543","TGA.AU","BK4585","CE","BK7001","OP.USD.HKCC","XAO.AU","BK4213","BK7067","XJO.AU","BK4109","MDR.AU","TGA","SEC.AU","BK4139","BK4156","BK7094","TLX","BK7039","BK4526","TLX.AU","ASX","BK4588","ASX.AU","XKO.AU"],"gpt_icon":0},{"id":"2572868845","title":"More sunscreens pulled from shelves amid SPF concernsA further 18 sunscreens have been recalled or paused from sale in Australia.2 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2572868845","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572868845?lang=en_us&edition=fundamental","pubTime":"2025-10-01 00:00","pubTimestamp":1759248000,"startTime":"0","endTime":"0","summary":"More sunscreens have been pulled from shelves amid concerns about their sun protection claims, as warmer weather approaches.A further 18 sunscreens have been recalled or paused from sale in Australia ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/more-sunscreens-pulled-from-shelves-amid-concerns-spf-may-be-as-low-as-four--c-20202614","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/more-sunscreens-pulled-from-shelves-amid-concerns-spf-may-be-as-low-as-four--c-20202614","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["BK4213","TGA","TGA.AU","BK7001"],"gpt_icon":0},{"id":"2569755096","title":"IMRA Surgical Announces Collaboration with Telix Pharmaceuticals to Advance Radio-Guided Surgery Education and Training","url":"https://stock-news.laohu8.com/highlight/detail?id=2569755096","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569755096?lang=en_us&edition=fundamental","pubTime":"2025-09-23 05:19","pubTimestamp":1758575940,"startTime":"0","endTime":"0","summary":"Strengthening Surgical Precision with SENSEI in Robotic-Assisted Surgery. IMRA Surgical has established itself as a leader in the development of synthetic surgical phantoms, medical models made from hydrogel that accurately simulate the response of actual human tissue. These models are transforming surgical training by enabling trainees to practice complex procedures in nearly lifelike conditions, without relying on cadavers or animal tissue. The company's innovative models are designed to reduce the learning curve for surgeons, ensuring that they gain hands-on experience with greater precision and efficiency, ultimately leading to fewer mistakes and better patient outcomes.IMRA Surgical and Telix will collaborate to offer specialized training courses and events focused around Telix's SENSEI technology. These initiatives are designed to support the global rollout of this technology and expand the market for both Telix's radio-guided surgery products and IMRA Surgical's high-fidelity ti","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2778287/5521890/Blue_and_Black_Horizontal_1_ID_5860eb00b4aa_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2778287/5521890/Blue_and_Black_Horizontal_1_ID_5860eb00b4aa_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/imra-surgical-announces-collaboration-with-telix-pharmaceuticals-to-advance-radio-guided-surgery-education-and-training-302563542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","XAO.AU","XKO.AU","BK4139","BK4213","BK4007","BK7001","BK4588","TGA.AU","BK4585","BK4109","TLX.AU","CE","TLX","TGA","IMRA","XJO.AU","SEC.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}